Incidence and Clinical Outcome of Acute Ischemic Cholecystitis After Transarterial Chemoembolization (Tace) of Hepatocellular Carcinoma

被引：0
|
作者：
Wagnetz, U.
Jaskolka, J.
Yang, P.
Jhaveri, K.
机构：
来源：
AMERICAN JOURNAL OF ROENTGENOLOGY | 2010年 / 194卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
E656
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A review of applying transarterial chemoembolization (TACE) method for management of hepatocellular carcinoma
    Ghanaati, Hossein
    Mohammadifard, Mahyar
    Mohammadifard, Mahtab
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2021, 10 (10) : 3553 - 3560
  • [22] Comparison of doxorubicin-eluting bead transarterial chemoembolization (DEB-TACE) with conventional transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma
    Ferrer Puchol, M. D.
    la Parra, C.
    Esteban, E.
    Vano, M.
    Forment, M.
    Vera, A.
    Cosin, O.
    RADIOLOGIA, 2011, 53 (03): : 246 - 253
  • [23] Acute tumor lysis syndrome after transarterial chemoembolization for hepatocellular carcinoma
    Shiba, Hiroaki
    Ishida, Yuichi
    Wakiyama, Shigeki
    Sakamoto, Taro
    Misawa, Takeyuki
    Yanaga, Katsuhiko
    CANCER SCIENCE, 2008, 99 (10): : 2104 - 2105
  • [24] The prognostic factors of recurrence in hepatocellular carcinoma after transarterial chemoembolization (TACE) induced complete response
    Jeong, Soung Won
    Choo, Jin Woo
    Jang, Jae Young
    Kim, Jin Nyoung
    Kwon, Soon Ha
    Lim, Dae Seop
    Park, Eui Ju
    Lee, Sae Hwan
    Kim, Sang Gyune
    Cha, Sang-Woo
    Kim, Young Seok
    Cho, Young Deok
    Kim, Hong Soo
    Kim, Boo Sung
    Choi, Dong Ho
    Kim, Young Jae
    HEPATOLOGY, 2012, 56 : 472A - 473A
  • [25] Factors Associated with Transarterial Chemoembolization Outcome for Hepatocellular Carcinoma
    Thuy Tran Ngoc
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 51 - 51
  • [26] Outcome of supraselective transarterial chemoembolization in patients with hepatocellular carcinoma
    Heinzow, Hauke Sebastian
    Meister, Tobias
    Nass, Dominik
    Koehler, Michael
    Spieker, Tilmann
    Wolters, Heiner
    Domschke, Wolfram
    Domagk, Dirk
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2011, 46 (02) : 201 - 210
  • [27] Inflammatory Markers are Associated with Outcome in Patients with Unresectable Hepatocellular Carcinoma (HCC) undergoing Transarterial Chemoembolization (TACE)
    McNally, M. E.
    Martinez, A.
    Malhotra, L.
    Bloomston, M.
    Schmidt, C. R.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S33 - S33
  • [28] The outcome of combination of transarterial chemoembolization (TACE) and percutancous ethanol injection (PEI) therapies for hepatocellular carcinoma (HCC)
    Kirikoshi, Hiroyuki
    Yoneda, Masato
    Fujita, Koji
    Saito, Satoru
    Nakajima, Atsushi
    GASTROENTEROLOGY, 2006, 130 (04) : A776 - A777
  • [29] Diffuse Recurrence of Hepatocellular Carcinoma After Liver Resection: Transarterial Chemoembolization (TACE) Combined With Sorafenib Versus TACE Monotherapy
    Yao, Wang
    Xue, Miao
    Lu, Mingjian
    Wang, Yu
    Zhao, Yue
    Wu, Yanqin
    Fan, Wenzhe
    Li, Jiaping
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [30] Comparison of balloon-occluded Transarterial chemoembolization (TACE) with conventional TACE for treatment of hepatocellular carcinoma
    Niinomi, Takuro
    Ishigami, Masatoshi
    Ishizu, Yoji
    Kuzuya, Teiji
    Honda, Takashi
    Hayashi, Kazuhiko
    Hirooka, Yoshiki
    Goto, Hidemi
    HEPATOLOGY, 2015, 62 : 417A - 417A
12345